noscript

News and Announcements

Analytica Receive FDA Approval for Over the Counter Clearance PeriCoach

  • Published July 13, 2016 10:32AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

12th July 2016, ASX Announcement

Analytica Ltd (ASX: ALT) is pleased to announce that the US Food and Drug Administration (FDA) has granted the company over-the-counter (OTC) clearance for the PeriCoach system, previously available in the US by prescription only.

The PeriCoach is a unique medical device that assists women to exercise their pelvic floor muscles in order to reduce or eliminate Stress Urinary Incontinence, a condition that affects 1 in 3 women.

“Women can use pelvic floor exercises or “Kegels” to reduce or eliminate urinary incontinence symptoms, and with PeriCoach now available over the counter, home training just got a lot more convenient,” said Leslie Rickey, MPH, MD, Associate Professor of Urology and of Obstetrics, Gynaecology and Reproductive Sciences and Fellowship Director of Female Pelvic Medicine and Reconstructive Surgery, Yale School of Medicine.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now